Rockville biopharm CASI acquires ANDA portfolio from Sandoz

Rockville-based CASI Pharmaceuticals Inc., a biopharmaceutical company dedicated to bringing quality pharmaceutical products to the Chinese and U.S. markets, announced Monday it has acquired a portfolio of 25 U.S. FDA-approved abbreviated new drug applications (ANDAs), one ANDA that FDA tentatively approved and three ANDAs that are pending FDA approval. CASI intends to select and commercialize certain ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *